Navigation Links
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
Date:12/26/2013

LA JOLLA, Calif., December 26, 2013 Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cellsmacrophagesare stimulated in response to pathogens. The molecule, termed "THRIL," helps regulate the immune response and shows an association with Kawasaki disease. The findings suggest that THRIL may contribute to other inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The study, published online in Proceedings of the National Academy of Sciences, measured large intergenic noncoding RNA (lincRNA) produced when the immune system is activated. One lincRNA was found to bind heterogenous nuclear ribonucleoprotein L (hnRNPL), creating a new molecule that regulates genetic control of TNF-alphaa potent cytokine that promotes inflammation. The authors named the molecule THRIL, after TNF-alpha and hnRNPL-related immunoregulatory lincRNA.

Noncoding RNAs as key regulators of immune response

Large noncoding RNA corresponds to the parts of the genome that do not code for protein.

"For some time we have known that noncoding regions of RNA play important roles in regulating the immune response to microbial pathogens," said Tariq Rana, Ph.D., senior author of the study and professor in the Sanford Children's Health Research Center and director of the RNA Biology Program at Sanford-Burnham. "When we realized that THRIL functioned to control the TNF-alpha gene, we wanted to see if it mirrors the progression in inflammatory diseases."

Collaborating with Jane Burns, M.D., professor of pediatrics at Rady Children's Hospital and UC San Diego, Rana's team measured THRIL levels in Kawasaki disease samples at different stages of the disease, and found that levels were at their lowest during the acute stage of the diseasewhen TNF-alpha levels are at their highest.

The findings suggest that THRIL could be a novel biomarker
'/>"/>

Contact: Susan Gammon
858-795-5012
Sanford-Burnham Medical Research Institute
Source:Eurekalert  

Page: 1 2

Related biology news :

1. The next era in discovering drugs in natures own medicine cabinet
2. Researchers develop tools for discovering new species
3. Discovering cell surface proteins behavior
4. Protein explains increased asthma severity in children exposed to diesel exhaust from traffic
5. Small protein plays big role in asthma severity
6. Probiotic bacterium lessens severity of Salmonella infections by hoarding iron
7. CSHL geneticists solve mystery of EEC Syndromes variable severity in children
8. Gut microbes could determine the severity of melamine-induced kidney disease
9. Researchers show prebiotic can reduce severity of colitis
10. Exposure to antibiotics linked to severity of allergic asthma: UBC research
11. Gene therapy for human skin disease produces long-term benefits
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
(Date:6/24/2015)... 24, 2015 The biologics safety testing market ... for the market include growth of the pharmaceutical and ... launches. Over the years, the number of drug approvals ... 2010, the FDA approved 225 drug applications and Health ... Europe accounted for 3,822 of the ...
(Date:6/24/2015)... 24, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Sharp has selected its industry-leading ... for its latest flagship smartphone device, the AQUOS ... million shipments of its fingerprint ID sensor technology, ... scalability and leadership in the biometrics market through ...
(Date:6/24/2015)... 2015 Biometry authentication provider KeyLemon today ... solution one face in. Logo ... face in, entering the expanding biometric authentication market ... biometric answer to the password problem. With advanced ... with KeyLemon, one face in allows users to ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... DURHAM, N.C. -- By mimicking the way embryonic stem cells ... believe they have taken an important first step toward growing ... disease. In a series of experiments using mouse embryonic ... own design to fashion a three-dimensional "patch" made up of ...
... release is available in Spanish . , ... fruits, nuts, whole grains and fish- appear less likely to ... Navarra, published in the October issue of Archives of ... has been found to be lower in Mediterranean than Northern ...
... BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader ... a member of the Oracle® PartnerNetwork, is showcasing its ... being held at the Moscone Center in San Francisco ... the Oracle Identity Assurance Partner Alliance, BIO-key will provide ...
Cached Biology News:New strategy for mending broken hearts? 2Mediterranean diet associated with reduced risk of depression 2BIO-key(R) International to Exhibit at Oracle(R) OpenWorld 2BIO-key(R) International to Exhibit at Oracle(R) OpenWorld 3
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) clinical market is poised ... molecular diagnostics industry. BCC Research reveals in its new report that the market drivers ... and a growing need for better diagnostics as part of a molecular diagnostics trend. ...
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... CHANDLER, Ariz. , July 1, 2015 ... announced it has earned three Gold, three Silver, and ... Business Awards gala held in Chicago ... recognized as the premier business awards program in the ... and recognizes our company,s strength in developing leaders, cultivating ...
(Date:7/1/2015)... InferMed , s ... will augment ... s olutions suite   Elsevier , ... and services, announced today the acquisition of  InferMed , a ... company. InferMed,s Arezzo technology supports clinicians in choosing ...
Breaking Biology Technology:NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4
... SAN MATEO, Calif., July 22, 2011 NeurogesX, Inc. ... on developing novel pain management therapies, today announced that ... purchase agreement in connection with a private placement to ... standard closing conditions, is expected to receive approximately $20 ...
... RO, ROG; OTCQX: RHHBY) announced today that the cobas ... for use in colorectal cancer. The cobas ... of colorectal cancer tissue that are predictive of individual ... antibody therapies. "By quickly and reliably ...
... have created a molecular polyhedron, a ground-breaking assembly that ... and consumer products, including magnetic and optical materials. ... the journal Science , was conducted by researchers ... Molecular Design Institute and the University of Milan,s Department ...
Cached Biology Technology:NeurogesX, Inc. Announces $20 Million Private Placement 2NeurogesX, Inc. Announces $20 Million Private Placement 3NeurogesX, Inc. Announces $20 Million Private Placement 4KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark 2KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark 3Chemists create molecular polyhedron -- and potential to enhance industrial and consumer products 2
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
Myeloid Marker (BM-1)...
Request Info...
Biology Products: